bn 50739 has been researched along with 1,2-distearoyllecithin in 1 studies
| Studies (bn 50739) | Trials (bn 50739) | Recent Studies (post-2010) (bn 50739) | Studies (1,2-distearoyllecithin) | Trials (1,2-distearoyllecithin) | Recent Studies (post-2010) (1,2-distearoyllecithin) |
|---|---|---|---|---|---|
| 57 | 0 | 1 | 450 | 1 | 140 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feuerstein, G; Rabinovici, R; Rudolph, AS; Yue, TL | 1 |
1 other study(ies) available for bn 50739 and 1,2-distearoyllecithin
| Article | Year |
|---|---|
Biological responses to liposome-encapsulated hemoglobin (LEH) are improved by a PAF antagonist.
Topics: Animals; Azepines; Blood Substitutes; Chemical Phenomena; Chemistry, Physical; Drug Interactions; Hemodynamics; Hemoglobins; Leukocyte Count; Liposomes; Male; Oxygen; Phosphatidylcholines; Platelet Activating Factor; Platelet Count; Rats; Rats, Inbred Strains; Thromboxane B2; Triazoles | 1990 |